Literature DB >> 6841854

Effects of chronic medical illness and dementia on the dexamethasone suppression test.

M Carnes, J C Smith, N H Kalin, S F Bauwens.   

Abstract

The dexamethasone suppression test (DST) was performed on 26 elderly male outpatients in a geriatric medical clinic. Patients with depression were excluded. All patients had two or more medical diagnoses. Fourteen patients also met DSM-III criteria for dementia. No patient had an abnormal DST result. The authors suggest that neither chronic medical illness nor dementia causes false-positive DST results in this patient population in an outpatient setting, and discuss the findings in relation to previous reports.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6841854     DOI: 10.1111/j.1532-5415.1983.tb04869.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  4 in total

1.  Synergy between chronic corticosterone and sodium azide treatments in producing a spatial learning deficit and inhibiting cytochrome oxidase activity.

Authors:  M C Bennett; G W Mlady; M Fleshner; G M Rose
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

2.  ACTH and cortisol secretion in patients with Alzheimer's disease.

Authors:  M Franceschi; L Airaghi; C Gramigna; G Truci; M G Manfredi; N Canal; A Catania
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-09       Impact factor: 10.154

3.  What is the evidence to support the use of therapeutic gardens for the elderly?

Authors:  Mark B Detweiler; Taral Sharma; Jonna G Detweiler; Pamela F Murphy; Sandra Lane; Jack Carman; Amara S Chudhary; Mary H Halling; Kye Y Kim
Journal:  Psychiatry Investig       Date:  2012-05-22       Impact factor: 2.505

4.  Glucocorticoid Resistance: Is It a Requisite for Increased Cytokine Production in Depression? A Systematic Review and Meta-Analysis.

Authors:  Andrew J Perrin; Mark A Horowitz; Jacob Roelofs; Patricia A Zunszain; Carmine M Pariante
Journal:  Front Psychiatry       Date:  2019-06-28       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.